World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00570440
Date of registration: 10/12/2007
Prospective Registration: No
Primary sponsor: FHI 360
Public title: Continuous Use of COCs
Scientific title: Continuous Versus Cyclic Use of Combined Oral Contraceptive Pills
Date of first enrolment: August 2007
Target sample size: 362
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00570440
Study type:  Interventional
Study design:  Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention  
Phase:  Phase 4
Countries of recruitment
Dominican Republic Guatemala Nicaragua
Contacts
Name:     Kavita Nanda, MD, MHS
Address: 
Telephone:
Email:
Affiliation:  FHI 360
Key inclusion & exclusion criteria

Inclusion Criteria:

- Age 18-30

- Currently has menstrual periods every 21-35 days

- Willing and able to be randomly assigned to one of the two study groups and to comply
with all study requirements

- Has signed the informed consent form

- Has a negative urine pregnancy test at enrollment

Exclusion Criteria:

- Has contraindications to COC use (see WHO MEC-3rd edition)

- Is in any other research study

- Has been pregnant in the past 3 months

- Is breastfeeding or has breastfed in the past 3 months

- Is currently using an IUD (women who agree to IUD removal are eligible once the IUD
is removed)

- Has had an injection of DMPA in the past 6 months

- Has had an injection of NET-EN in the past 3 months

- Has used combined injectables, oral contraceptive pills, implants, or a hormonal IUD
in the past 2 months

- Has had any of the following conditions since her last pregnancy, or since menarche
if never pregnant:

- Pelvic infection treated with antibiotics

- Diagnosis of infertility

- Endometriosis



Age minimum: 18 Years
Age maximum: 30 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Pregnancy Prevention
Intervention(s)
Drug: Oral contraceptives--ethinyl estradiol, levonorgestrel
Primary Outcome(s)
12 month cumulative COC discontinuation probabilities [Time Frame: 12 months]
Secondary Outcome(s)
Pregnancy rates through 6 and 12 months; 6 month cumulative discontinuation probabilities; acceptability; bleeding and other side effects; hemoglobin/hematocrit [Time Frame: 12 months]
Secondary ID(s)
9964
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
La AsociaciĆ³n Pro Bienestar de la Familia de Guatemala (APROFAM)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history